Roy Fleischmann
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies 267
- Systemic Lupus Erythematosus Research 96
- Spondyloarthritis Studies and Treatments 35
- Hematology top 0.02%
- Autoimmune and Inflammatory Disorders Research 151
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 93
- Immunology top 0.2%
- Biosimilars and Bioanalytical Methods 28
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 65
-
- Monoclonal and Polyclonal Antibodies Research 31
- Co-authors
- Michael SchiffJoel M. KremerMark C. GenoveseRonald van VollenhovenLarry W. MorelandEdward KeystoneMichael E. WeinblattDavid Gruben
- Cited by
- RheumatologyHematologyGenetics
- Journals
- Annals of the Rheumatic Diseases (118 papers)RMD Open (24 papers)Lara D. Veeken (20 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Roy Fleischmann
335 papers receiving 22.0k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Rheumatology 16.7k
- Hematology 8.1k
- Genetics 3.9k
- Immunology 6.4k
- Pathology and Forensic Medicine 2.4k
Countries citing papers authored by Roy Fleischmann
This map shows the geographic impact of Roy Fleischmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Fleischmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Fleischmann more than expected).
Fields of papers citing papers by Roy Fleischmann
This network shows the impact of papers produced by Roy Fleischmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Fleischmann. The network helps show where Roy Fleischmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roy Fleischmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 1 | |
| 7 | 2020 | 44 | |
| 8 | Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial | 2018 | 1 |
| 9 | 2018 | 30 | |
| 10 | 2018 | 130 | |
| 11 | CERTOLIZUMAB PEGOL FOR THE TREATMENT OF PSORIATIC ARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-PSA TRIAL | 2016 | 2 |
| 12 | 2016 | 2 | |
| 13 | 2014 | 13 | |
| 14 | Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis | 2013 | 5 |
| 15 | 2013 | 210 | |
| 16 | 2013 | 1 | |
| 17 | SAFETY UPDATE ON CERTOLIZUMAB PEGOL (CZP) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) | 2010 | 5 |
| 18 | 2009 | 1 | |
| 19 | 2009 | 89 | |
| 20 | 2007 | 6 |
About Roy Fleischmann
Roy Fleischmann is a scholar working on Rheumatology, Hematology and Genetics, having authored 347 papers that have together received 22.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (267 papers), Autoimmune and Inflammatory Disorders Research (151 papers), Systemic Lupus Erythematosus Research (96 papers), Chronic Lymphocytic Leukemia Research (93 papers), Lymphoma Diagnosis and Treatment (65 papers), Spondyloarthritis Studies and Treatments (35 papers), Monoclonal and Polyclonal Antibodies Research (31 papers) and Biosimilars and Bioanalytical Methods (28 papers). The work is most often cited by research in Rheumatology (16.7k citations), Hematology (8.1k citations) and Genetics (3.9k citations). Roy Fleischmann has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Michael Schiff, Joel M. Kremer, Mark C. Genovese, Ronald van Vollenhoven, Larry W. Moreland, Edward Keystone, Michael E. Weinblatt, David Gruben, Gene V. Wallenstein and Samuel H. Zwillich. Their work appears in journals such as Annals of the Rheumatic Diseases, RMD Open, Lara D. Veeken, Rheumatology and Therapy and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.